Home/Filings/4/0000950170-24-076698
4//SEC Filing

HALE DAVID F 4

Accession 0000950170-24-076698

CIK 0001260990other

Filed

Jun 23, 8:00 PM ET

Accepted

Jun 24, 4:05 PM ET

Size

5.5 KB

Accession

0000950170-24-076698

Insider Transaction Report

Form 4
Period: 2024-06-20
HALE DAVID F
Director
Transactions
  • Award

    Stock Options

    2024-06-20+3,3003,300 total
    Exercise: $8.10Exp: 2034-06-20Common Stock (3,300 underlying)
Footnotes (1)
  • [F1]One-twelfth of the number of shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the grant date, subject to the Reporting Person's continued service through such vesting date.

Documents

1 file

Issuer

Oncternal Therapeutics, Inc.

CIK 0001260990

Entity typeother
IncorporatedCA

Related Parties

1
  • filerCIK 0001024004

Filing Metadata

Form type
4
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:05 PM ET
Size
5.5 KB